By Giulia Petroni
Atos SE said Wednesday that it would challenge a U.S. District Court jury verdict that found Syntel Inc. liable for misappropriation of trade secrets and copyright infringement in a case against Cognizant Technology Solutions Corp. and its TriZetto healthcare subsidiary.
Atos acquired Syntel in 2018.
The French IT company said it "considers that the jury's verdict is not supported by the evidence presented during the trial or the applicable law [...] and considers the amount of damages grossly out of proportion to the acts complained of."
The jury has specified an amount of damages due to Cognizant and TriZetto of about $855 million, the company said. Atos contends that the maximum amount of damages legally available to TriZetto in this case is about $8.5 million.
Atos said it has already filed a motion challenging the validity of TriZetto's claims and will seek to file a further motion to overturn the verdict.
Write to Giulia Petroni at firstname.lastname@example.org
(END) Dow Jones Newswires